The cumulative incidence of CRLM has declined, with survival gains mainly in synchronous cases, highlighting the need for ...

Researchers at Weill Cornell Medicine with an international team have used liver biopsies to identify cellular and molecular markers that can potentially be used to predict whether and when pancreatic ...

How spreading tumour cells gain the ability to grow in organs away from where they originated is not fully understood. The discovery that normal liver cells help invading tumour cells to thrive in ...

Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to ...

A subgroup analysis of the phase 3 FOCUS study (NCT02678572) shows that the Melphalan/Hepatic Delivery System (HDS; HEPZATO ...

The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...

Microscopic changes in the liver can be used to predict if, and where, pancreatic cancer may spread in the body. The discovery has the potential to provide new ways of predicting the course of the ...

Persistently elevated liver enzymes may be caused by certain types of cancer, including liver, colon, breast, stomach, pancreas, and skin cancers. Liver enzymes are proteins produced by your liver.